Inside Scarlet’s $50M Series B: The Business of Reviewing AI Medical Devices
Dr. Dereck Mush, MD, MBANo. 14 Investors
Halle Tecco
Founder, Rock Health; Adjunct Professor, Columbia Business School, Rock Health, Columbia Business School • United States
Founder of Rock Health and Natalist, angel investor and business school faculty shaping how digital health companies are built and funded.
Find on LinkedInThe Signal
She built the first dedicated digital health seed fund and the research that the sector still quotes, and she now teaches, invests and writes across the same field with unusual consistency.
Who Halle Tecco is
Founder of Rock Health and Natalist, angel investor and business school faculty shaping how digital health companies are built and funded.
She built the first dedicated digital health seed fund and the research that the sector still quotes, and she now teaches, invests and writes across the same field with unusual consistency.
Loading the full dossier
At a glance
- Role
- Founder, Rock Health; Adjunct Professor, Columbia Business School
- Organisation
- Rock Health, Columbia Business School
- Platforms
- LinkedIn, Podcast, Books
- Based in
- United States, North America
Influence Score 89.4editorial estimate, see how it is built
Reach (25% weight)88
Audience size across LinkedIn, X, YouTube, podcasts and newsletters.
Engagement (20% weight)85
How much the audience actually reacts, comments, shares and subscribes.
Credibility (25% weight)90
Clinical, research, operating or investing track record behind the commentary.
Consistency (15% weight)87
Publishing cadence and how reliably they show up with original work.
Industry impact (15% weight)87
Whether decision makers, policy and capital actually move on what they say.
Scores are subjective editorial estimates compiled by our research desk from public profiles and published work. They are opinion, not measurement, and they are not a judgement of any person's character or ability.
Also in Investors
Did we miss something?
Change, add or remove details on this profile. Our desk reviews every request.
This profile is compiled by our research desk from public sources and is published as editorial commentary. Want a correction, an update, or your profile removed? and see our corrections and removals policy.
Related reading
Dr. Dereck Mush, MD, MBA
Beyond the Genetic Ceiling: How Scholar Rock's FDA Approval for Isembyld Unlocks the Muscle-Directed Neuromuscular Economy
Dr. Dereck Mush, MD, MBAKeep exploring